Methicillin-resistant Staphylococcus aureus in orthopaedic surgery

Journal of Bone and Joint Surgery - Series B

Volumn 90, Issue 11, 2008, Pages 1401-1406

  Patel, A ^a   Calfee, R P ^a,b   Plante, M ^a   Fischer, S A ^a   Arcand, N ^a   Born, C ^a  

^a BROWN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; METICILLIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; QUINOLONE; RIFAMPICIN; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; VANCOMYCIN;

ATHLETE; AWARENESS; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; DRUG ACTIVITY; DRUG EFFICACY; DRUG MEGADOSE; HEALTH CARE MANAGEMENT; HIGH RISK POPULATION; HOSPITAL ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; HUMAN; IMPLANTATION; INFECTION CONTROL; LOW DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; ORTHOPEDIC SURGERY; OSTEOMYELITIS; PATHOGENICITY; POSTOPERATIVE INFECTION; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; ORTHOPEDICS; STAPHYLOCOCCAL INFECTIONS;

EID: 55549091713     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.90B11.20771     Document Type: Review

References (49)

1. Cookson B, Schmidt F.-J, Flint AC. Staphylococci: discovery. In: Fluit AC, Schmitz F.-J, eds. MRSA: current perspectives. Wymondham: Caister Press, 2003:1-10.
2. Yocum RR, Waxman DJ, Rasmussen JR, Strominger JL. Mechanism of penicillin action: penicillin and substrate bind covalently to the same active site serine in two bacterial D-alanine carboxypeptidases. Proc Natl Acad Sci USA 1979;76:2730-4.
3. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;7:178-82.
4. Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002;99:7687-92.
5. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44.
6. Kluytmans-Vandenbergh MF, Kluytmans JA. Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 2006;12(Suppl 1):9-15.
7. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-9.
8. Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community associated MRSA nasal carriage. Clin Infect Dis 2005;41:159-66.
9. Lindenmayer JM, Schoenfeld S, O'Grady R, Carney JK. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998;158:895-9.
10. Stacey AR, Endersby KE, Chan PC, Marples RR. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med 1998;32:153-4.
11. No authors listed. CDC: methicillin resistant Staphylococcus aureus infections among competitive sports participants: Colorado, Indiana, Pennsylvania and Los Angeles county, 2000-2003. MMWR 2003;52:793-5.
12. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468-75.
13. Rihn JA, Michaels MG, Harner CD. Community-acquired methicillin-resistant staphylococcus aureus: an emerging problem in the athletic population. Am J Sports Med 2005;33:1924-9.
14. Ferry T, Etienne J. Community acquired MRSA in Europe. BMJ 2007;335:947-8.
15. Carnicer-Pont D, Bailey KA, Mason BW, et al. Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control study. Epidemiol Infect 2006;134:1167-73.
16. Coello R, Jiménex J, Garcia M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994;13:74-81.
17. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-20.
18. Wertheim HF, Vos MC, Otta A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004;364:703-5.
19. Pujol M, Peña C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996;100:509-16.
20. Kluytmans JA, Mouton JW, VandenBergh MF, et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996;17:780-5.
21. Engeman JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-8.
22. Roche SJ, Fitzgerald D, O'Rourke A, McCabe JP. Methicillin-resistant Staphylococcus aureus in an Irish orthopaedic centre: a five-year analysis .J Bone Joint Surg [Br] 2006;88-B:807-11.
23. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003;36:281-5.
24. Trampuz A, Widmer AF. Infections associated with orthopedic implants. Curr Opin Infect Dis 2006;19:349-56.
25. Ando E, Monden K, Mitsuhata R, Kariyama R, Kumon H. Biofilm formation among methicillin-resistant Staphylococcus aureus isolated from patients with urinary tract infection. Acta Med Okayama 2004;58:207-14.
26. Jabra-Rizk MA, Meiller PF, James CE, Shirtliff ME. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob Agents Chemother 2006;50:1463-9.
27. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere GA. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000;21:319-23.
28. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen M, et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double blind, randomized, placebo controlled study. Clin Infect Dis 2002;35:353-8.
29. Wilcox MH, Hall J, Pike H, et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003;54:196-201.
30. Merrer J, Pisica-Donose G, Leneveu M, Pauthier F. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage among patients with femoral neck fractures: implication for antibiotic prophylaxis. Infect Control Hosp Epidemiol 2004;25:515-17.
31. Sanderson PJ. The role of methicillin-resistant Staphylococcus aureus in orthopedic implant surgery. J Chemother 2001;13:89-95.
32. Osmon DR. Antimicrobial resistance: guidelines for the practicing orthopedic surgeon. J Bone Joint Surg [Am] 2001;83-A:1891-901.
33. Lamp KC, Friedrich LV, Mendez-Vigo L, Russo R. Clinical experience with daptomycin for the treatment of patients with osteomyelitis. Am J Med 2007;120:13-20.
34. Razonable RR, Osmon DR, Steckelberg JM. Linezolid therapy for orthopedic infections. Mayo Clin Proc 2004;79:1137-44.
35. Gemmell CG, Edwards DI, Fraise AP, et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 2006;57:589-608.
36. Bucholz EW, Elson RA, Engelbrecht E, et al. Management of deep infection of total hip replacement. J Bone Joint Surg [Br] 1981;63-B:342-53.
37. Nelson CL. The current status of material used for depot delivery of drugs. Clin Orthop 2004;427:72-8.
38. Marks KE, Nelson CL, Lautenschlager EP. Antibiotic-impregnated acrylic bone cement. J Bone Joint Surg [Am] 1976;58-A:358-64.
39. Joseph TN, Chen AL, Di Cesare PE. Use of antibiotic-impregnated cement in total joint arthroplasty. J Am Acad Orthop Surg 2003;11:38-47.
40. Klekamp J, Dawson JM, Haas DW, DeBoer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 1999;14:339-646.
41. Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bonecement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement system (PROSTSLAC). J Arthroplasty 1998;13:331-8.
42. Hanssen AD, Spangehl MJ. Practical applications for antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop 2004;427:79-85.
43. Chiu FY, Chen CM, Lin CF, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomised study of three hundred and forty knees. J Bone Joint Surg [Am] 2002;84-A:759-62.
44. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg [Br] 1997;79-B:590-5.
45. McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopedic infections. Clin Orthop 2004;427:101-6.
46. Pittet D, Mourouga P, Perneger TV. Compliance with handwashing in a teaching hospital: Infection Control Program. Ann Intern Med 1999;130:126-30.
47. Johnston P, Norrish AR, Brammar T, et al. Reducing methicillin-resistant Staphylococcus aureus (MRSA) patient exposure by infection control measures. Ann R Coll Engl 2005;87:123-5.
48. Biant LC, Teare EL, Williams WW, Tuite JD. Eradication of methicillin resistant Staphylococcus aureus by "ring fencing" of elective orthopedic beds. BMJ 2004;329:149-51.
49. Nixon M, Jackson B, Varghese P, Jenkins D, Taylor G. Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control .J Bone Joint Surg [Br] 2006;88-B:812-70.